RSV Diagnostic Device
We are now enrolling for a clinical trial evaluating the effectiveness of a diagnostic device for respiratory syncytial virus (RSV).
Respiratory syncytial virus (RSV) causes infections of the lungs and respiratory tract. Most children have been infected with the virus by age 2 but it can also affect older children and adults. In adults and older, healthy children, RSV symptoms are mild and typically mimic the common cold. However, for anyone with a weak immune system, such as n infants, older adults, people with heart and lung disease, RSV infection can be severe or even life-threatening.
If you are interested in participating in this study or have questions about your eligibility, perform a self-check below and request a phone screen.
Participant Enrollment Criteria
Have 2 or more symptoms such as cough, fever, runny nose, congestion, etc.
Must not be a healthcare worker (doctor, nurse, dentist, etc.)
Additional criteria may apply
Participants Will Receive
Receive access to study related medical equipment and care
Receive compensation up to $200
Location and Time
All appointments are located at Eastside Research Associates in Redmond, WA
Up to 60 minutes depending on study eligibility